Kobayashi Pharmaceutical Co. Ltd. | Ownership
Companies that own Kobayashi Pharmaceutical Co. Ltd.
MFS International (UK) Ltd.
5,047,500
6.15%
6,600
0.76%
07/31/2018
The Vanguard Group, Inc.
1,520,621
1.85%
62,600
0%
07/31/2018
Nomura Asset Management Co., Ltd.
1,056,098
1.29%
-143,448
0.04%
07/31/2018
Norges Bank Investment Management
900,439
1.1%
-73,487
0.01%
12/31/2017
Templeton Investment Counsel LLC
727,816
0.89%
-74,100
0.24%
03/31/2018
Fidelity Management & Research Co.
667,700
0.81%
-132,700
0.01%
07/31/2018
BlackRock Fund Advisors
656,500
0.8%
-3,300
0%
09/06/2018
Daiwa Asset Management Co. Ltd.
490,200
0.6%
9,700
0.04%
07/31/2018
Nikko Asset Management Co., Ltd.
442,499
0.54%
-2,401
0.02%
09/03/2018
Massachusetts Financial Services Co.
423,400
0.52%
-31,400
0.01%
07/31/2018
| Address |
KDX Kobayashi Doshomachi Building
Osaka Osaka 541
Japan
|
|
Employees
|
- |
| Website |
http://www.kobayashi.co.jp |
| Updated |
07/08/2019 |
| Kobayashi Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals, non-pharmaceuticals, deodorizers, and sanitary products. It operates through the following segments: Domestic Consumer Products Business, Overseas Consumer Products Business, Direct Marketing Business, and Other. The Domestic Consumer Products Business segment manufactures and sells body warmers, healthcare, household, and skincare products. |
